However, western blotting indicated that there was a tendency for the subcutaneous tumours formed from tRNAiMet-overexpressing cells to have elevated fibronectin and β1 integrin content, suggesting that tRNAiMet may drive α5β1 integrin-dependent processes in these tumours (Fig. 5B). Here, FN1 is linked to neoplasm.